{"title":"M","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0025","DOIUrl":null,"url":null,"abstract":"This chapter presents information on neonatal drugs that begin with M, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Magnesium sulfate (Magnesium sulphate = former BAN), Mebendazole, Mefloquine, Melatonin, Meningococcal vaccines, Mercaptamine (Cysteamine— former BAN), Meropenem, Methadone, Methyldopa, Methylthioninium chloride (Methylene blue = former BAN), Metoclopramide, Metronidazole, Micafungin, Miconazole, Midazolam, Formula milk thickeners and anti-reflux milks, Milrinone, Misoprostol, Mivacurium, Morphine, and Mupirocin","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"24 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neonatal Formulary","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780198840787.003.0025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This chapter presents information on neonatal drugs that begin with M, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Magnesium sulfate (Magnesium sulphate = former BAN), Mebendazole, Mefloquine, Melatonin, Meningococcal vaccines, Mercaptamine (Cysteamine— former BAN), Meropenem, Methadone, Methyldopa, Methylthioninium chloride (Methylene blue = former BAN), Metoclopramide, Metronidazole, Micafungin, Miconazole, Midazolam, Formula milk thickeners and anti-reflux milks, Milrinone, Misoprostol, Mivacurium, Morphine, and Mupirocin
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
